![]() Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. | ![]() Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. | ![]() Gracell Gracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer. | Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 2017 | Founding Date 1993 | Founding Date 1993 |
Type | Type Public | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US | Locations London, GB HQ Stevenage, GB | Locations Suzhou, CN HQ | Locations Shenyang, CN HQ | Locations Cambridge, US HQ |
Employees | Employees 14868% increase | Employees 153 | Employees 348 | Employees 5,2325% decrease | Employees 1,7461% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 144.4 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 451 | Twitter followers N/A | Twitter followers N/A | Twitter followers 22.1 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 |
Alexa Website Rank | Alexa Website Rank 264882 | Alexa Website Rank 211045 | Alexa Website Rank 413940 | Alexa Website Rank 416661 | Alexa Website Rank 684602 |
Employee Rating | Employee Rating 3.3 | Employee Rating 3.7 | Employee Rating N/A | Employee Rating 3 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥366k (FY, 2021) | Revenue (est.) ¥6.4b (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥777.3m (FY, 2021) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥366k (FY, 2021) | Gross profit ¥5.7b (FY, 2021) | Gross profit N/A |
Net income | Net income ($342.3m) (FY, 2021) | Net income ($61.1m) (FY, 2021) | Net income (¥451.8m) (FY, 2021) | Net income ¥1.6b (FY, 2021) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 100m | Total funding raised $ 138.1m | Total funding raised $ 185m | Total funding raised $ 15.2m | Total funding raised N/A |
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View companyGracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer.
View company3sbio (三生制药集团) is a company that develops biopharmaceuticals.
View companyTakeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View company